Benjamin Izar MD

Oncology•New York, NY

Clinical Fellow in Medicine, Massachusetts General Hospital

Request appointment

161 Fort Washington AveFl 9New York, NY 10032
Book by Phone+1(419) 728-2459

Overview of Dr. Izar

Dr. Benjamin Izar is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Giessen Faculty of Medicine and has been in practice 16 years. He is one of 127 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 403 doctors at New York-Presbyterian Hospital who specialize in Oncology. He also speaks multiple languages, including German. He has more than 100 publications and over 500 citings.

Education & Training

Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 2011 - 2012
University of Giessen Faculty of MedicineClass of 2010

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NY State Medical License 2019 - 2027
MA State Medical License 2014 - 2021
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Cancer Chemoimmunotherapy: Time Will Tell.
Sam O Kleeman, Yosef Riazat-Kesh, Richard Carvajal, Melina E Marmarelis, Dirk Schadendorf
Cancer Immunology Research. 2026-08-04
Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Clinical Models: MEKiAUTO.
Brian W Labadie, Aleksandar Obradovic, Alexander G Raufi, Urszula N Wasko, Lorenzo Tomassoni
JCO Precision Oncology. 2026-06-01
1 citations
Single-cell and spatial profiling in cancer biology and clinical oncology.
Chris J Frangieh, Joy Linyue Fan, Johannes C Melms, Parin Shah, Elham Azizi
Nature Cancer. 2026-04-01

Lectures

Single-cell RNA-sequencing and -imaging of melanoma ecosystems reveals sources of resistance to immune checkpoint blockade.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

Pharming Group to Host Webcast on Findings of a New Study Published in Cell Advancing Functional Classification of Variants of Uncertain Significance (VUS) to Improve APDS DiagnosisJune 24th, 2025
New Method Speeds Diagnosis of Rare Genetic DiseaseJune 20th, 2025
Expanding Research on Dormant Cancer Cells Aims to Prevent MetastasisApril 10th, 2025

Grant Support

Restoring anti-tumor immunity in chromosomally unstable tumorsCOLUMBIA UNIVERSITY HEALTH SCIENCES2026–2031
Systematic variant-to-pathway, phenotype, and precision treatment response evaluation in genetic disorders of the immune system (GDIS)COLUMBIA UNIVERSITY HEALTH SCIENCES2026–2031
Multi-cellular interactions defining the human brain metastatic nicheCOLUMBIA UNIVERSITY HEALTH SCIENCES2023–2028
Mechanisms of liver metastasis and associated resistance to immunotherapyCOLUMBIA UNIVERSITY HEALTH SCIENCES2021–2028
Mechanisms of liver metastasis and associated resistance to immunotherapyCOLUMBIA UNIVERSITY HEALTH SCIENCES2021–2028